Zoom Webinar

This webinar was recorded live February 20, 2023 @ 3:00 PM - 4:00 PM EST

While there has been plenty of attention in recent months on the rollout of legal access to psychedelics—in Oregon, Colorado, and beyond—what often gets lost in the hype is just how much psychedelic use is growing across the globe, independent of these stories.

Beyond the currently legal avenues of ketamine therapy, psilocybin services in Oregon, and clinical trials, more and more people are also seeking international retreats, underground guides, community ceremonies, and mail-order mushrooms. Not everyone who uses psychedelics in these contexts will require professional support, but many will—and almost all will benefit from a workforce of health professionals who are educated about the risks and benefits of psychedelic use–whether it be their therapist, social worker, or family doctor.

In this month’s installment of Fluence’s webinar series, join Psychologist and Co-Founder Ingmar Gorman, Fluence’s Director of the Psychedelic Harm Reduction and Integration Program Dr. Alex Camargo, and LCSW and integration therapist Amy Johnson for a discussion on the opportunities and challenges of doing this kind of work right now as a clinician.

Webinar attendees will learn:

  • What psychedelic harm reduction and integration is and how it differs from psychedelic-assisted therapy

  • What it’s like to practice this modality as a clinician right now, including how this modality can create unique opportunities to expand your practice 

  • How Fluence’s curriculum supports this work, as well as practical information about where to start with certification

A Q&A period will follow. 


Chief Executive Officer, Co-Founder and Trainer

Ingmar Gorman, PhD

Dr. Ingmar Gorman is a psychologist who specializes in helping people who use psychedelics and other psychoactive compounds. He received his clinical training at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University in 2017. Dr. Gorman was formerly the Director of the Psychedelic Education and Continuing Care Program at the Center for Optimal Living and is now the co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. Along with Dr. Paleos, he is currently site co-principal investigator and therapist on a Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder.

Psychedelic Harm Reduction and Integration Certificate Program Director and Trainer

Alexander Camargo, PsyD

Dr. Alex Camargo is a psychologist based in New York City and maintains a private practice in Manhattan. His work is heavily influenced by psychoanalytic and attachment theories where he works with clients to address anxiety, depression, life transitions and spiritual crises. In addition, he provides psychedelic harm reduction and integration, helping clients prepare for psychedelic experiences, incorporate insights or cope with challenges post-experience. He has also been employed to be a study therapist on a clinical trial investigating the impact of psilocybin on the treatment of body dysmorphic disorder at New York Psychiatric Institute. Dr. Camargo’s clinical training focused on providing mental health services in low-fee clinics and hospitals to traditionally underserved communities the Bronx, Brooklyn, and Nassau County.

Amy Johnson, LCSW-C

Certificate Program graduate